第62回日本核医学会学術総会/第42回日本核医学技術学会総会学術大会

講演情報

[世界核]

第13回世界核医学会プログラム » Fukushima Session

Fukushima Session

The progress of development of At-211 targeted alpha particle therapy at Fukushima Medical University and possibilities of combined therapy with external-beam radiation and immunotherapy

2022年9月9日(金) 17:30 〜 18:30 第1会場 (国立京都国際会館 1F Main Hall)

Chair:Shunichi Yamashita (Vice president, Fukushima medical university, Fukushima, Japan), Tohru Shiga (Advanced clinical Research Center, Fukushima medical university, Fukushima, Japan)

[WFS-2] Synthesis of At-211 MABG

Kazuhiro Takahashi (Advanced clinical Research Center, Fukushima medical university, Fukushima, Japan)